Page 1212 - Williams Hematology ( PDFDrive )

1186 Part IX: Lymphocytes and Plasma Cells Chapter 76: Functions of T Lymphocytes: T-cell Receptors for Antigen 1187

61. Waldmann H, Hilbrands R, Howie D, Cobbold S: Harnessing FOXP3+ regulatory 98. van Leeuwen EMM, Sprent J, Surh CD: Generation and maintenance of memory CD4+
T cells for transplantation tolerance. J Clin Invest 124:1439–1445, 2014. T Cells. Curr Opin Immunol 21:167–172, 2009.
62. Rubtsov YP, Niec RE, Josefowicz S, et al: Stability of the regulatory T cell lineage in vivo. 99. Plebanski M, Saunders M, Burtles SS, et al: Primary and secondary human in vitro
Science 329:1667–1671, 2010. T-cell responses to soluble antigens are mediated by subsets bearing different CD45
63. Sakaguchi S, Miyara M, Costantino CM, Hafler DA: FOXP3+ regulatory T cells in the isoforms. Immunology 75:86–91, 1992.
human immune system. Nat Rev Immunol 10:490–500, 2010. 100. Alexander DR: The CD45 tyrosine phosphatase: A positive and negative regulator of
64. Garín MI, Chu C-C, Golshayan D, et al: Galectin-1: A key effector of regulation medi- immune cell function. Semin Immunol 12:349–359, 2000.
ated by CD4+CD25+ T cells. Blood 109:2058–2065, 2007. 101. Tortorella C, Schulze-Koops H, Thomas R, et al: Expression of CD45RB and CD27
65. Liu H, Yang PS, Zhu T, et al: Characterization of fibrinogen-like protein 2 (FGL2): identifies subsets of CD4+ memory T cells with different capacities to induce B cell
Monomeric FGL2 has enhanced immunosuppressive activity in comparison to oligo- differentiation. J Immunol 155:149–162, 1995.
meric FGL2. Int J Biochem Cell Biol 45:408–418, 2013. 102. Clement LT: Functional and phenotypic properties of “naive” and “memory” CD4+
66. Korn T, Bettelli E, Oukka M, Kuchroo VK: IL-17 and Th17 Cells. Annu Rev Immunol T cells in the human. Immunol Res 10:189–195, 1991.
27:485–517, 2009. 103. Sallusto F, Lenig D, Forster R, et al: Two subsets of memory T lymphocytes with distinct
67. McGeachy MJ, Chen Y, Tato CM, et al: The interleukin 23 receptor is essential for the homing potentials and effector functions. Nature 401:708–712, 1999.
terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat 104. Huster KM, Busch V, Schiemann M, et al: Selective expression of IL-7 receptor on
Immunol 10:314–324, 2009. memory T cells identifies early CD40L-dependent generation of distinct CD8+ mem-
68. Boniface K, Bak-Jensen KS, Li Y, et al: Prostaglandin E2 regulates Th17 cell differen- ory T cell subsets. Proc Natl Acad Sci U S A 13:5610–5615, 2004.
tiation and function through cyclic AMP and EP2/EP4 receptor signaling. J Exp Med 105. Kallies A: Distinct regulation of effector and memory T-cell differentiation. Immunol
206:535–548, 2009. Cell Biol 86:325–332, 2008.
69. Ivanov II, McKenzie BS, Zhou L, et al: The orphan nuclear receptor RORγt directs the 106. Lenschow DJ, Walunas TL, Bluestone JA: CD28/B7 system of T cell costimulation.
differentiation program of proinflammatory IL-17+ T helper cells. Cell 126:1121–1133, Annu Rev Immunol 14:233–258, 1996.
2006. 107. van der Merwe PA, Bodian DL, Daenke S, et al: CD80 (B7–1) binds both CD28 and
70. Yang XO, Panopoulos AD, Nurieva R, et al: STAT3 regulates cytokine-mediated gener- CTLA-4 with a low affinity and very fast kinetics. J Exp Med 185:393–404, 1997.
ation of inflammatory helper T cells. J Biol Chem 282:9358–9363, 2007. 108. Greene JL, Leytze GM, Emswiler J, et al: Covalent dimerization of CD28/CTLA-4 and
71. Bettelli E, Carrier Y, Gao W, et al: Reciprocal developmental pathways for the genera- oligomerization of CD80/CD86 regulate T cell costimulatory interactions. J Biol Chem
tion of pathogenic effector TH17 and regulatory T cells. Nature 441:235–238, 2006. 271:26762–26771, 1996.
72. Mangan PR, Harrington LE, O’Quinn DB, et al: Transforming growth factor-beta 109. Yokosuka T, Saito T: The immunological synapse, TCR microclusters, and T cell acti-
induces development of the T(H)17 lineage. Nature 441:231–234, 2006. vation, in Immunological Synapse, edited by Saito T, Batista FD, pp 81–107. Springer,
73. Annunziato F, Cosmi L, Santarlasci V, et al: Phenotypic and functional features of Berlin, 2010.
human Th17 cells. J Exp Med 204:1849–1861, 2007. 110. Rudd CE, Taylor A, Schneider H: CD28 and CTLA-4 coreceptor expression and signal
74. Kryczek I, Banerjee M, Cheng P, et al: Phenotype, distribution, generation, and func- transduction. Immunol Rev 229:12–26, 2009.
tional and clinical relevance of Th17 cells in the human tumor environments. Blood 111. Powell JD, Ragheb JA, Kitagawa-Sakakida S, Schwartz RH: Molecular regulation of
114:1141–1149, 2009. interleukin-2 expression by CD28 co-stimulation and anergy. Immunol Rev 165:287–300,
75. Harrington LE, Hatton RD, Mangan PR, et al: Interleukin 17-producing CD4+ effector 1998.
T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 112. Lumsden JM, Williams JA, Hodes RJ: Differential requirements for expression of
6:1123–1132, 2005. CD80/86 and CD40 on B cells for T-dependent antibody responses in vivo. J Immunol
76. Miossec P, Korn T, Kuchroo VK: Interleukin-17 and type 17 helper T cells. N Engl J Med 170:781–787, 2003.
361:888–898, 2009. 113. Fathman CG, Lineberry NB: Molecular mechanisms of CD4+ T-cell anergy. Nat Rev
77. Ouyang W, Kolls JK, Zheng Y: The biological functions of T helper 17 cell effector Immunol 7:599–609, 2007.
cytokines in inflammation. Immunity 28:454–467, 2008. 114. Beverly B, Kang S-M, Lenardo MJ, Schwartz RH: Reversal of in vitro T cell clonal
78. Iwakura Y, Nakae S, Saijo S, Ishigame H: The roles of IL-17A in inflammatory immune anergy by IL-2 stimulation. Int Immunol 4:661–671, 1992.
responses and host defense against pathogens. Immunol Rev 226:57–79, 2008. 115. Ise W, Kohyama M, Nutsch KM, et al: CTLA-4 suppresses the pathogenicity of self
79. Milner JD, Brenchley JM, Laurence A, et al: Impaired TH17 cell differentiation in sub- antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms. Nat Immunol
jects with autosomal dominant hyper-IgE syndrome. Nature 452:773–776, 2008. 11:129–135, 2010.
80. Ma CS, Chew GY, Simpson N, et al: Deficiency of Th17 cells in hyper IgE syndrome due 116. Masteller EL, Chuang E, Mullen AC, et al: structural analysis of CTLA-4 function in
to mutations in STAT3. J Exp Med 205:1551–1557, 2008. vivo. J Immunol 164:5319–5327, 2000.
81. Abou Chakra CN, Sirard S, Valiquette L: Risk factors for recurrence, complications and 117. Maltzman JS, Turka LA: T-cell costimulatory blockade in organ transplantation. Cold
mortality in Clostridium difficile infection: A systematic review. PLoS One 9:e98400, Spring Harb Perspect Med 3:a015537, 2013.
2014. 118. Duraiswamy J, Kaluza KM, Freeman GJ, Coukos G: Dual blockade of PD-1 and
82. Furst DE, Emery P: Rheumatoid arthritis pathophysiology: Update on emerging cytok- CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in
ine and cytokine-associated cell targets. Rheumatology 53:1560–1569, 2014. tumors. Cancer Res 73:3591–3603, 2013.
83. Martin JC, Baeten DL, Josien R: Emerging role of IL-17 and Th17 cells in systemic lupus 119. Wolchok JD, Kluger H, Callahan MK, et al: Nivolumab plus ipilimumab in advanced
erythematosus. Clin Immunol 154:1–12, 2014. melanoma. N Engl J Med 369:122–133, 2013.
84. Sie C, Korn T, Mitsdoerffer M: Th17 cells in central nervous system autoimmunity. Exp 120. Chen L, Flies DB: Molecular mechanisms of T cell co-stimulation and co-inhibition.
Neurol 262 Pt A:18–27, 2014. Nat Rev Immunol 13:227–242, 2013.
85. Troncone E, Marafini I, Pallone F, Monteleone G: Th17 cytokines in inflammatory 121. Pardoll DM: The blockade of immune checkpoints in cancer immunotherapy. Nat Rev
bowel diseases: Discerning the good from the bad. Int Rev Immunol 32:526–533, 2013. Cancer 12:252–264, 2012.
86. Newcomb DC, Peebles RS Jr: Th17-mediated inflammation in asthma. Curr Opin 122. Wang S, Zhu G, Chapoval AI, et al: Costimulation of T cells by B7-H2, a B7-like mole-
Immunol 25:755–760, 2013. cule that binds ICOS. Blood 96:2808–2813, 2000.
87. Elloso MM, Gomez-Angelats M, Fourie AM: Targeting the Th17 pathway in psoriasis. 123. Nishimura H, Nose M, Hiai H, et al: Development of lupus-like autoimmune diseases
J Leukoc Biol 92:1187–1197, 2012. by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor.
88. Crotty S: Follicular helper CD4 T cells (TFH). Annu Rev Immunol 29:621–663, 2011. Immunity 11:141–151, 1999.
89. Liu X, Yan X, Zhong B, et al: Bcl6 expression specifies the T follicular helper cell pro- 124. Chen W, Zhu C: Mechanical regulation of T-cell functions. Immunol Rev 256:160–176,
gram in vivo. J Exp Med 209:1841–1852, 2012. 2013.
90. Kaplan MH: Th9 cells: Differentiation and disease. Immunol Rev 252:104–115, 2013. 125. Schmidt S, Moser M, Sperandio M: The molecular basis of leukocyte recruitment and
91. Jager A, Kuchroo VK: Effector and regulatory T-cell subsets in autoimmunity and tissue its deficiencies. Mol Immunol 55:49–58, 2013.
inflammation. Scand J Immunol 72:173–184, 2010. 126. Shimizu Y, van Seventer GA, Horgan KJ, Shaw S: Roles of adhesion molecules in T-cell
92. Jones CP, Gregory LG, Causton B, et al: Activin A and TGF-β promote T(H)9 cell- recognition: Fundamental similarities between four integrins on resting human T cells
mediated pulmonary allergic pathology. J Allergy Clin Immunol 129:1000–1010.e3, (LFA-1, VLA-4, VLA-5, VLA-6) in expression, binding, and costimulation. Immunol
2012. Rev 114:109–143, 1990.
93. Purwar R, Schlapbach C, Xiao S, et al: Robust tumor immunity to melanoma mediated 127. Davis SJ, Ikemizu S, Wild MK, Van der Merwe PA: CD2 and the nature of protein inter-
by interleukin-9-producing T cells. Nat Med 18:1248–1253, 2012. actions mediating cell–cell recognition. Immunol Rev 163:217–236, 1998.
94. Lu Y, Hong S, Li H, et al: Th9 cells promote antitumor immune responses in vivo. J Clin 128. Huppa JB, Davis MM: T-cell-antigen recognition and the immunological synapse. Nat
Invest 122:4160–4171, 2012. Rev Immunol 3:973–983, 2003.
95. Williams MA, Bevan MJ: Effector and memory CTL differentiation. Annu Rev Immunol 129. Grakoui A, Bromley SK, Sumen C, et al: The immunological synapse: A molecular
25:171–192, 2007. machine controlling T cell activation. Science 285:221–227, 1999.
96. Lees JR, Farber DL: Generation, persistence and plasticity of CD4 T-cell memories. 130. Dustin ML, Depoil D: New insights into the T cell synapse from single molecule tech-
Immunology 130:463–470, 2010. niques. Nat Rev Immunol 11:672–684, 2011.
97. Murali-Krishna K, Lau LL, Sambhara S, et al: Persistence of memory CD8 T cells in
MHC class I-deficient mice. Science 286:1377–1381, 1999.

Kaushansky_chapter 76_p1175-1188.indd 1187 9/17/15 4:01 PM